Five-year median 13.8×, middle half 12.1–17.0×, range 9.8–25.3×. Now 11.8×: −15% below its own median, higher than 20% of those quarters.Each quarter priced at its own trailing Cash FFO per share · the band is the 25th–75th percentile
Where the cash goes
TTM through Jun 30, 2026 · $B
Cash FFO 1.11B = net income 0.25B + depreciation 1.10B − 0.24B other non-cash items · dividends 0.84B · retained 0.27B
Against its type
DOC (blue) vs. the other Healthcare REITs on the board (3), grey
P/Cash FFO11.8× vs. 28.2×
Dividend yield6.4% vs. 3.2%
Cash FFO payout76% vs. 70%
Net debt / EBITDA5.4× vs. 5.0×
Interest cover4.8× vs. 4.3×
EBITDA margin55% vs. 50%
Type averages are the plain mean of the other REITs of the same property type with a usable window.
Quarter by quarter
8 quarters · Sep 30, 2024 → Jun 30, 2026 · a gap is a dropped quarter